Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still’s disease

Background: High-dose glucocorticoids (GC) are first-line treatment for adult-onset Still’s disease (AOSD); however, some of the patients remain refractory to initial GC therapy, or rapidly relapse. The aim of this study was to identify prognostic factors for poor treatment response to initial GC th...

Full description

Bibliographic Details
Main Authors: Hasegawa, H. (Author), Hosoya, T. (Author), Kimura, N. (Author), Kondo, F. (Author), Mori, M. (Author), Sugihara, T. (Author), Umezawa, N. (Author), Yasuda, S. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Online Access:View Fulltext in Publisher